Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Labbe Invest AB
AB
Active
Org 5593231276
Nordenskiöldsgatan 86
Intermediation service activities for real estate activities · NACE 6831
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 989K
+193% vs 2023
EBITDA margin
17.1%
+612% vs 2023
Equity ratio
65.8%
Financial strength
Net profit 2024
SEK 152K
+561% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 989K
+193%
EBITDA
SEK 169K
+612%
Net profit
SEK 152K
+561%
Total assets
SEK 383K
+199%
Equity
SEK 252K
+152%
Employees
1
—
Company information
Legal name
Labbe Invest AB
Org number
5593231276
Legal form
Aktiebolag
NACE code
6831 · Intermediation service activities for real estate activities
Founded
17 juni 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Fastighetsförmedling
Contact
Address
Nordenskiöldsgatan 86
Email
joelerleman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Intermediation service activities for real estate activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
0M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
795
259
337
989
Staff expenses
—
—
—
—
EBITDA
402
−28
−33
169
Depreciation & amort.
−0
−0
−0
−0
EBIT
402
−28
−33
169
Net financials
—
—
1
8
Profit before tax
402
−28
−33
178
Tax
−86
−0
−0
−26
Net profit
316
−28
−33
152
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
482
198
128
383
Equity
341
133
100
252
Long-term debt
0
0
0
0
Short-term debt
142
65
28
131
Total debt
142
65
28
131
Financial ratios
5-year trend
EBITDA margin
17.1%
This company
15.8%
Market median
+8% vs market
2021
2024
Equity ratio
65.8%
This company
38.2%
Market median
+72% vs market
2021
2024
Return on equity
60.3%
This company
18.4%
Market median
+228% vs market
2021
2024
Net profit margin
15.4%
This company
8.1%
Market median
+90% vs market
2021
2024
Asset turnover
2.58×
This company
1.12×
Market median
+130% vs market
2021
2024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-06-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LM
Lena Maria Nilsson Erleman
Deputy Board Member
2022
JA
Joel Anders Erleman
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Labbe Invest AB also hold positions in
0
other companies.
Person
Role here
Other companies
Lena Maria Nilsson Erleman
Deputy Board Member
0 companies
Joel Anders Erleman
Board of Directors
0 companies